Imunon, Inc. (IMNN) vs Lucyd, Inc (LUCY)
A side-by-side comparison of Imunon, Inc. and Lucyd, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNN
Imunon, Inc.
$1.23HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
LUCY
Lucyd, Inc
$0.93HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT
Total return — IMNN vs LUCY
growth of $100 · dividends reinvested · last 4yIMNN -96.7% (-57.4%/yr)LUCY -99.2% (-70.5%/yr)IMNN compounded faster over this window
IMNN LUCY
IMNN vs LUCY: by the numbers
- •LUCY is the larger company ($6M vs $5M market cap).
- •Both run net losses; IMNN's is the smaller (0.00% vs -225.28% net margin).
Metrics side by side
Valuation
| Metric | IMNN | LUCY |
|---|---|---|
| P/S ratio | N/A | 1.72 |
| P/B ratio | 1.23 | 0.85 |
Profitability
| Metric | IMNN | LUCY |
|---|---|---|
| Gross margin | 0.00% | 22.79% |
| Operating margin | 0.00% | -319.16% |
| Net margin | 0.00% | -225.28% |
| ROE | -351.30% | -111.42% |
| ROIC | -126.69% | -122.15% |
Growth (annualized)
| Metric | IMNN | LUCY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 64.52% |
| Total return CAGR (5Y) | -63.83% | N/A |
Go deeper
Dig into the metrics
Imunon ROELucyd ROEImunon operating marginLucyd operating marginImunon revenue growthLucyd revenue growthImunon free cash flowLucyd free cash flow
Imunon & Lucyd appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.